C Bañuls1,2,3, S Rovira-Llopis1,2, S Lopez-Domenech1, N Diaz-Morales1, A Blas-Garcia3, S Veses1,2, C Morillas1,2, V M Victor1,3,4, M Rocha1,3, A Hernandez-Mijares1,2,5. 1. Service of Endocrinology. University Hospital Doctor Peset, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain. 2. Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain. 3. CIBERehd-Department of Pharmacology and Physiology, University of Valencia, Valencia, Spain. 4. Department of Physiology, University of Valencia, Valencia, Spain. 5. Department of Medicine, University of Valencia, Valencia, Spain.
Abstract
BACKGROUND: Oxidative stress and inflammation are related to obesity, but the influence of metabolic disturbances on these parameters and their relationship with endoplasmic reticulum (ER) stress is unknown. Therefore, this study was performed to evaluate whether metabolic profile influences ER and oxidative stress in an obese population with/without comorbidities. SUBJECTS AND METHODS: A total of 113 obese patients were enrolled in the study; 29 were metabolically healthy (MHO), 53 were metabolically abnormal (MAO) and 31 had type 2 diabetes (MADO). We assessed metabolic parameters, proinflammatory cytokines (TNFα and IL-6), mitochondrial and total reactive oxygen species (ROS) production, glutathione levels, antioxidant enzymes activity, total antioxidant status, mitochondrial membrane potential and ER stress marker expression levels (glucose-regulated protein (GRP78), spliced X-box binding protein 1 (XBP1), P-subunit 1 alpha (P-eIF2α) and activating transcription factor 6 (ATF6). RESULTS: The MAO and MADO groups showed higher blood pressure, atherogenic dyslipidemia, insulin resistance and inflammatory profile than that of MHO subjects. Total and mitochondrial ROS production was enhanced in MAO and MADO patients, and mitochondrial membrane potential and catalase activity differed significantly between the MADO and MHO groups. In addition, decreases in glutathione levels and superoxide dismutase activity were observed in the MADO vs MAO and MHO groups. GRP78 and CHOP protein and gene expression were higher in the MAO and MADO groups with respect to MHO subjects, and sXBP1 gene expression was associated with the presence of diabetes. Furthermore, MAO patients exhibited higher levels of ATF6 than their MHO counterparts. Waist circumference was positively correlated with ATF6 and GRP78, and A1c was positively correlated with P-Eif2α. Interestingly, CHOP was positively correlated with TNFα and total ROS production and GRP78 was negatively correlated with glutathione levels. CONCLUSIONS: Our findings support the hypothesis that both inflammation and oxidative stress are involved in the induction of ER stress signaling pathways in the leukocytes of metabolically unhealthy obese vs healthy obese subjects.
BACKGROUND: Oxidative stress and inflammation are related to obesity, but the influence of metabolic disturbances on these parameters and their relationship with endoplasmic reticulum (ER) stress is unknown. Therefore, this study was performed to evaluate whether metabolic profile influences ER and oxidative stress in an obese population with/without comorbidities. SUBJECTS AND METHODS: A total of 113 obesepatients were enrolled in the study; 29 were metabolically healthy (MHO), 53 were metabolically abnormal (MAO) and 31 had type 2 diabetes (MADO). We assessed metabolic parameters, proinflammatory cytokines (TNFα and IL-6), mitochondrial and total reactive oxygen species (ROS) production, glutathione levels, antioxidant enzymes activity, total antioxidant status, mitochondrial membrane potential and ER stress marker expression levels (glucose-regulated protein (GRP78), spliced X-box binding protein 1 (XBP1), P-subunit 1 alpha (P-eIF2α) and activating transcription factor 6 (ATF6). RESULTS: The MAO and MADO groups showed higher blood pressure, atherogenic dyslipidemia, insulin resistance and inflammatory profile than that of MHO subjects. Total and mitochondrial ROS production was enhanced in MAO and MADO patients, and mitochondrial membrane potential and catalase activity differed significantly between the MADO and MHO groups. In addition, decreases in glutathione levels and superoxide dismutase activity were observed in the MADO vs MAO and MHO groups. GRP78 and CHOP protein and gene expression were higher in the MAO and MADO groups with respect to MHO subjects, and sXBP1 gene expression was associated with the presence of diabetes. Furthermore, MAO patients exhibited higher levels of ATF6 than their MHO counterparts. Waist circumference was positively correlated with ATF6 and GRP78, and A1c was positively correlated with P-Eif2α. Interestingly, CHOP was positively correlated with TNFα and total ROS production and GRP78 was negatively correlated with glutathione levels. CONCLUSIONS: Our findings support the hypothesis that both inflammation and oxidative stress are involved in the induction of ER stress signaling pathways in the leukocytes of metabolically unhealthy obese vs healthy obese subjects.
Authors: Rachel P Wildman; Robert Kaplan; JoAnn E Manson; Aleksandar Rajkovic; Stephanie A Connelly; Rachel H Mackey; Lesley F Tinker; J David Curb; Charles B Eaton; Sylvia Wassertheil-Smoller Journal: Obesity (Silver Spring) Date: 2011-01-13 Impact factor: 5.002
Authors: Philip Barter; Y Ruth McPherson; Kijoung Song; Y Antero Kesäniemi; Robert Mahley; Gérard Waeber; Thomas Bersot; Vincent Mooser; Dawn Waterworth; Scott M Grundy Journal: J Clin Endocrinol Metab Date: 2007-03-27 Impact factor: 5.958
Authors: F Allagnat; M Fukaya; T C Nogueira; D Delaroche; N Welsh; L Marselli; P Marchetti; J A Haefliger; D L Eizirik; A K Cardozo Journal: Cell Death Differ Date: 2012-06-01 Impact factor: 15.828
Authors: Christine Vogel; Raquel de Sousa Abreu; Daijin Ko; Shu-Yun Le; Bruce A Shapiro; Suzanne C Burns; Devraj Sandhu; Daniel R Boutz; Edward M Marcotte; Luiz O Penalva Journal: Mol Syst Biol Date: 2010-08-24 Impact factor: 11.429
Authors: Elena Maria Yubero-Serrano; Javier Delgado-Lista; Patricia Peña-Orihuela; Pablo Perez-Martinez; Francisco Fuentes; Carmen Marin; Isaac Tunez; Francisco Jose Tinahones; Francisco Perez-Jimenez; Helen M Roche; Jose Lopez-Miranda Journal: Exp Mol Med Date: 2013-06-21 Impact factor: 8.718
Authors: Jake E Lowry; Batbayar Tumurbaatar; Claudia D'Agostino; Erika Main; Traver J Wright; Edgar L Dillon; Tais B Saito; Craig Porter; Clark R Andersen; Douglas L Brining; Janice J Endsley; Melinda Sheffield-Moore; Elena Volpi; Rong Fang; Nicola Abate; Demidmaa R Tuvdendorj Journal: Br J Nutr Date: 2019-12-28 Impact factor: 3.718
Authors: J Góralska; U Raźny; A Polus; J Stancel-Możwiłło; M Chojnacka; A Gruca; A Zdzienicka; A Dembińska-Kieć; B Kieć-Wilk; B Solnica; M Malczewska-Malec Journal: Int J Obes (Lond) Date: 2017-12-13 Impact factor: 5.095